Loading resource…

Chronic Disease Innovation Centre, Seven Oaks General Hospital; Department of Community Health Sciences, Faculty of Science, University of Manitoba; Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba; Neil John Mclean
The document provides a comprehensive analysis of 31 trials involving 33,048 patients with diabetic kidney disease, focusing on the comparative risks of AKI and hyperkalemia when using dual RAAS inhibitors versus single agents. It highlights significant findings regarding the differential risks associated with steroidal and non-steroidal mineralocorticoid receptor antagonists (MRAs). The authors suggest that further research is needed to explore these risks in real-world clinical settings.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

CARDIOVASCULAR COMPLICATIONS IN CHRONIC KIDNEY DISEASE: A REVIEW FROM THE EUROPEAN RENAL AND CARDIOVASCULAR MEDICINE WORKING GROUP OF THE EUROPEAN RENAL ASSOCIATION
Same clinical topic · Nephrology

OBESITY IN CKD: CORE CURRICULUM 2026
Same clinical topic · Nephrology

OBESITY IN CKD: CORE CURRICULUM 2026
Same clinical topic · Nephrology

ACUTE GLOMERULONEPHRITIS
Same clinical topic · Nephrology

DISEASE MODIFICATION IN LUPUS NEPHRITIS: TOWARDS A PATHOPHYSIOLOGY-BASED TREATMENT PARADIGM
Same clinical topic · Nephrology

Effects of correction rate for severe hyponatremia in the intensive care unit on patient outcomes
Same clinical topic · Nephrology

CURRENT UNDERSTANDING OF SODIUM-GLUCOSE TRANSPORTER 2 INHIBITORS IN CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME
Same clinical topic · Nephrology

A COMPREHENSIVE REVIEW OF ACUTE CARDIO-RENAL SYNDROME: NEED FOR NOVEL BIOMARKERS
Same clinical topic · Nephrology

TIRZEPATIDE AND PREVENTION OF CHRONIC KIDNEY DISEASE
Same clinical topic · Nephrology